The monoamine hypothesis for the pathophysiology of paraphilic disorders: An update

Annals of the New York Academy of Sciences

Volumn 989, Issue , 2003, Pages 86-94

  Kafka, Martin P ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MCLEAN HOSPITAL   (United States)

Author keywords

Axis I comorbidity; Medical therapy; Monoaminergic dysregulation; Neurotransmitters; Paraphilic disorders; Psychopathology; Serotonin; Sex offender; Sexual behavior

Indexed keywords

DOPAMINE; MONOAMINE; NEUROTRANSMITTER; NORADRENALIN; SEROTONIN;

ANIMAL BEHAVIOR; APPETITE; COMORBIDITY; CONFERENCE PAPER; HUMAN; HYPOTHESIS; MENTAL DISEASE; MONOAMINERGIC SYSTEM; MOTIVATION; NEUROTRANSMISSION; PATHOPHYSIOLOGY; SEXUAL BEHAVIOR; SEXUAL CRIME; SEXUAL DEVIATION;

ANIMALIA; MAMMALIA;

EID: 0038389760     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb07295.x     Document Type: Conference Paper

References (64)

1. ABEL, G.G. & OSBORN, C. (1992). The paraphilias: The extent and nature of sexually deviant and criminal behavior. In Psychiatric Clinics of North America: Clinical forensic psychiatry (Vol. 15, pp. 675-687). Philadelphia, PA: W.B. Saunders.
2. ABOUESH, A. & CLAYTON, A. (1999). Compulsive voyeurism and exhibitionism: A clinical response to paroxetine. Archives of Sexual Behavior, 28, 23-30.
3. AMERICAN PSYCHIATRIC ASSOCIATION. (1980). Diagnostic and statistical manual of mental disorders (3rd ed.). Washington, DC: American Psychiatric Association.
4. AMERICAN PSYCHIATRIC ASSOCIATION. (2000). Diagnostic and statistical manual of mental disorders (4th ed., Text Rev.). Washington, DC: American Psychiatric Association.
5. AMERICAN PSYCHIATRIC ASSOCIATION (1994). Sexual and gender identity disorders. In Diagnostic and Statistical Manual of Mental Disorders (4th ed., pp. 493-538). Washington, DC: American Psychiatric Association.
6. BAUM, M.J. & STARR, M.D. (1980). Inhibition of sexual behavior by dopamine antagonists or serotonin agonist drugs in castrated male rats given estradiol or dihydrotestosterone. Pharmacology, Biochemisrty, and Behavior, 13, 47-67.
7. BORISOVA, N.A., PROSHLYAKOVA, E.V., SAPRONOVA, A.Y. & UGRUMOV, M.V. (1996). Androgen-dependent sex differences in the hypothalamic serotoninergic system. European Journal of Endocrinology. 134, 232-235.
8. BRIKEN, P., NIKA, E. & BERNER, W. (2001). Treatment of parapahilia with luteinizing hormone-releasing hormone agonists. Journal of Sex and Marital Therapy, 27, 45-55.
9. BRADFORD, J.M.W. (2001). The neurobiology, neuropharmacology, and pharmacological treatment of paraphilias and compulsive sexual behavior. Canadian Journal of Psychiatry, 46, 26-33.
10. BRADFORD, J.M. & GRATZER, T.G. (1995). A treatment for impulse control disorders and paraphilia: A case report. Canadian Journal of Psychiatry, 40, 4-5.
11. COMINGS, D.E. (2001). Clinical and molecular genetics of ADHD and Tourette's Syndrome. In J. Wasserstein, L.E. Wolf & F.F. Lefever (Eds.), Adult attention deficit disorder: Brain mechanisms and life outcomes (Vol. 931, pp. 50-83). New York. New York Academy of Sciences.
12. CRENSHAW, T.L. & GOLDBERG, J.P. (1996). Sexual pharmacology,: Drugs that affect sexual function. New York. W.W. Norton.
13. EVERITT, B.J. (1983). Monoamines and the control of sexual behavior. Psychological Medicine, 13, 715-720.
14. EVERITT, B.J. (1995). Neuroendocrine mechanisms underlying appetitive and consummatory elements of masculine sexual behavior. In J. Bancroft (Ed.), The pharmacology of sexual function and dysfunction (pp. 15-31). Amsterdam: Elsevier Science.
15. EVERITT, B.J. & BANCROFT, J. (1991). Of rats and men: The comparative approach to male sexuality. In J. Bancroft, C.M. Davis & H.J. Ruppel, Jr. (Eds.), Annual Review of Sex Research (Vol. 2, pp. 77-118). Mt. Vernon, IA: Society for the Scientific Study of Sex.
16. FAGO, D.P. (1999). Comorbidity of attention deficit hyperactivity disorder in sexually aggressive children and adolescents. In B. Schwartz (Ed.), The sex offender: Theoretical advances, treating special populations and legal developments (Vol. 3. pp. 16.1-16.15). Kingston, NJ. Civic Research Institute.
17. GALLI, V.B., RAUTE, N.J., MCCONNVILLE, B.J. & MCELROY, S.L. (1998). An adolescent male with multiple paraphilias treated successfully with fluoxetine. Journal of Child and Adolescent Psychopharmacology, 8, 195-197.
18. GALLI, V., MCELROY, S.L., SOUTELLO, C.A., et al. (1999). The psychiatric diagnoses of twenty two adolescents who have sexually molested other children. Comprehensive Psychiatry, 40, 85-87.
19. GREENBERG, D.M. & BRADFORD, J.M.W. (1997).Treatment of the paraphilic disorders: A review of the role of the selective serotonin reuptake inhibitors. Sexual Abuse: Journal of Treatment and Research, 9, 349-360.
20. GREENBERG, D.M., BRADFORD, J.M.W., CURRY, S. & O'ROURKE, A. (1996). A comparison of treatment of paraphilias with three serotonin reuptake inhibitors: A retrospective study. Bulletin of the American Acadamy of Psychiatry Law, 24, 525-532.
21. HANSON, R. & HARRIS, A. (2000). Where should we intervene? Dynamic predictors of sexual offense recidivism. Criminal Justice and Behavior, 27, 6-35.
22. HULL, E.M., LORRAIN, D.S., DU, J., et al. (1999). Hormone-neurotransmitter interactions in the control of sexual behavior. Behavioural Brain Research, 105, 105-116.
23. JUORIO, A.V., LI, X.M., GONZALEZ, A., CHEDRESE, P.J. & MURPHY, B.D. (1991). Effects of active immunization against gonadotrophin-releasing hormone on theconcentrations of noradrenaline, dopamine, 5-hydroxytryptamine and some of their metabolites in the brain and sexual organs of male rats. Neuroendocrinology; 54, 49-54.
24. KAFKA, M.P. (1991a). Successful antidepressant treatment of nonparaphilic sexual addictions and paraphilias in men. Journal of Clinical Psychiatry, 52, 60-65.
25. KAFKA, M.P. (1991b). Successful treatment of paraphilic coercive disorder (a rapist) with fluoxetine hydrochloride. British Journal of Psychiatry, 158, 844-847.
26. KAFKA, M.P. (1994). Sertraline pharmacotherapy for paraphilias and paraphilia-related disorders; An open trial. Annals of Clinical Psychiatry, 6, 189-195.
27. KAFKA, M.P. (1997a). A monoamine hypothesis for the pathophysiology of paraphilic disorders. Archives of Sexual Behavior, 26, 337-352.
28. KAFKA, M.P. (1997b). Hypersexual desire in males: An operational definition and clinical implications for men with paraphilias and paraphilia-related disorders. Archives of Sexual Behavior, 26, 505-526.
29. KAFKA, M.P. & HENNEN, J. (2000). Psychostimulant augmentation during treatment with selective serotonin reuptake inhibitors in males with paraphilias and paraphilia-related disorders: A case series. Journal of Clinical Psychiatry, 61, 664-670.
30. KAFKA, M. & HENNEN, J. (2002). A DSM IV Axis I comorbidity study of males (n=120) with paraphilias and paraphilia-related disorders. Journal of Sexual Abuse, 14, 347-366.
31. KAFKA, M.P. & HENNEN. J. (in press). Hypersexual desire in males: Are males with paraphilias different from males with paraphilia-related disorders? Sexual Abuse.
32. KAFKA, M.P. & PRENTKY, R. (1992). Fluoxetine treatment of nonparaphilic sexual addictions and paraphilias in men. Journal of Clinical Psychiatry, 52, 351-358.
33. KAFKA, M.P. & PRENTKY, R,A. (1998). Attention deficit hyperactivity disorder in males with paraphilias and paraphilia-related disorders: A comorbidity study. Journal of Clinical Psychiatry, 59, 388-396.
34. KAVOUSSI, R., ARMSTEAD, P. & COCCARO, E. (1997). The neurobiology of impulsive aggression. Psychiatric Clinics of North America, 20, 395-403.
35. KENDALL, D. & TONGE, S. (1976). Monoamine concentrations in eight areas of the brain of mature and immature male rats and the effects of injected hormones [proceedings]. Journal of Pharmacy and Pharmacology, 28(Suppl.), 37P.
36. KNIGHT, R. & CERCE, D. (1999). Validation and revision of the Multidimensional Assessment of Sex and Aggression. Psycholigica Belgica, 39, 135-161.
37. KOGAN, B.M., TKACHENKO, A.A., DROZDOV, A.Z., et al. (1995). Monoamine metabolism in different forms of paraphilia [In Russian]. Zhurnal Nevropatologii i Psikhiatrii Imeni S S Korsakova, 95, 52-56.
38. KRUEGER, R.B. & KAPLAN, M.S. (2001). Depot-leuprolide for treatment of paraphilias: A report of 12 cases. Archives of Sexual Behavior, 30, 409-422.
39. KRUESI, M.J.P., FINE, S., VALLADARES, L. PHILLIPS, R.A. & RAPOPORT, J.L. (1992). Paraphilias: A double-blind crossover comparison of clomipramine versus desipramine. Archives of Sexual Behavior, 21, 587-593.
40. LEVIN, R.J. (1994). Human male sexuality; Appetite and arousal, desire and drive. In C.R. Legg & D. Booth (Eds.), Appetite: Neural and behavioral bases (pp. 128-164). Oxford: Oxford University Press.
41. LEVITSKY, A.M. & OWENS, N.J. (1999). Pharmacologic treatment of hypersexuality and paraphilias in nursing home residents. Journal of the American Geriatrics Society, 47, 231-234.
42. LORRAIN, D.S., MATUSZEWICH, L., FRIEDMAN, R.D. & HULL, E.M. (1997). Extracellular serotonin in the lateral hypothalamic area is increased during the postejaculatory interval and impairs copulation in male rats. Journal of Neuroscience, 17, 9361-9366.
43. LORRAIN, D., RIOLO, J., MATUSZEWICH, L. & HULL, E. (1999). Lateral hypothalamic serotonin inhibits nucleas accumbens dopamine: Implications for sexual satiety. Journal of Neuroscience, 19, 7648-7652.
44. MAES, M., DE VOS, N., VAN HUNSEL, F., et al. (2001a). Pedophilia is accompanied by increased plasma concentrations of catecholamines, in particular epinephrine. Psychiatry Research, 103, 43-49.
45. MAES, M., VAN WEST, D., DE VOS, N., et al. (2001b). Lower baseline plasma cortisol and prolactin together with increased body temperature and higher m-CPP-induced cortisol responses in men with pedophilia. Neuropsychopharmacology, 24, 37-46.
46. MAS, M. (1995). Neurobiological correlates of masculine sexual behavior. Neuroscience and Biobehavioral Reviews, 19, 261-277.
47. MAS, M., FUMERO, B., FERNANDEZ-VERA, J.R. & GONZALEZ-MORA, J.L. (1995). Neurochemical correlates of sexual exhaustion and recovery as assessed by in vitro microdialysis. Brain Research, 675, 13-19.
48. MCELROY, S.L., SOUTELLO, C.A., TAYLOR, P., et al. (1999). Psychiatric features of 36 convicted sexual offenses. Journal of Clinical Psychiatry, 60, 414-420.
49. MCKENNA, K.E. (2001). Neural circuitry involved in sexual function. Journal of Spinal Cord Medicine, 24, 148-154.
50. MESTON, C.M. & FROLICH, P.F. (2000). The neurobiology of sexual functioning. Archives of General Psychiatry, 57, 1012-1032.
51. MONTEJO, A.L., LLORCA, G., IZQUIERDO, J.A. & RICO-VILLADERMOS, F. (2001). Dysfunction. Incidence of sexual dysfunction associated with antidepressant agents: A prospective multicenter study of 1022 patients. Journal of Clinical Psychiatry, 62(Suppl. 3), 10-20.
52. O'DONOHUE, W., REGEV, L.G. & HAGSTROM, A. (2000). Problems with the DSM IV diagnosis of pedophilia. Sex Abuse, 12, 95-106.
53. PFAUS, J.G. (1996). Homologies of animal and human sexual behaviors. Hormones and Behavior, 30, 187-200.
54. POMERANTZ, S.M. (1995). Monoamine influences on male sexual behavior of nonhuman primates. In J. Bancroft (ed.), The pharmacology of sexual function and dysfunction (pp. 201-211). Amsterdam: Elsevier Science.
55. PRENTKY, R.A. & BURGESS, A.W. (2000). Diagnosis and classification. In R.A. Prentky & A.W. Burgess (Eds.), Forensic management of sexual offenders (pp. 25-70). New York: Kluver Academis/Plenum.
56. RAYMOND, N.C., COLEMAN, E., OHLERKING, F., CHRISTENSON, G.A. & MINER, M. (1999). Psychiatric comorbidity in pedophilic sex offenders. American Journal of Psychiatry, 156, 786-788.
57. RESSLER, K.J. & NEMEROFF, C.B. (2000). Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depression and Anxiety, 12(Suppl. 1), 2-19.
58. ROSLER, A. & WITZTUM, E. (1998). Treatment of men with paraphilia with a long-acting analogue of gonadotropin-releasing hormone. New England Journal of Medicine, 338, 416-422.
59. RUBINSTEIN, E.B. & ENGEL, N.L. (1996). Successful treatment of transvestic fetishism with sertraline and lithium. Journal of Clinical Psychiatry, 57, 92.
60. SOUBRIE, P. (1986). Reconciling the role of central serotonin neurons in human and animal behavior. Behavioural Brain Research, 9, 319-364.
61. THIBAUT, F., CORDIER, B. & KUHN, J.M. (1993). Effect of a long-lasting gonadotrophin hormone-releasing agonist in six cases of severe male paraphilia. Acta Psychiatrica Scandinacica, 87, 445-450.
62. YATES, A. (2001). Conduct disorder. In G.O. Gabbard (Ed.), The treatment of psychiatric disorders (3rd ed., Vol. 1, pp. 177-190). Washington, DC: American Psychiatric Publishing.
63. ZHANG, L., MA, W., BARKER, J.L. & RUBINOW, D.R. (1999). Sex differences in expression of serotonin receptors (subtypes 1A and 2A) in rat brain: A possible role of testosterone. Neuroscience, 94, 251-259.
64. ZOHAR, J., KAPLAN, Z. & BENJAMIN, J. (1994). Compulsive exhibitionism successfully treated with fluvoxamine: A controlled case study. Journal of Clinical Psychiatry, 55, 86-88.